BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 544 found
  Current Search:  schizophrenia: 544     

HTML
100%
Autobiographical memory impaired in schizophrenia
MedWire News: Patients with schizophrenia have difficulty recalling meaningful memories from their personal past, report researchers who say this finding may underlie disturbances in patients' sense of identity.

Lead investigator...

MedWire News:  Jan 7 2009 12:13AM
Matching: schizophrenia
Find similar documents
HTML
100%
Mental health care is failing
NHS psychiatry in Crewe and Nantwich is as useful as a chocolate teapot.

They don't understand schizophrenia and I suffer as a result.

You get sent to Coventry for complaining and trying to argue calmly and trying to discuss a...

Stoke-on-Trent Sentinel:  Jan 7 2009 3:52PM
Matching: schizophrenia
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at JPMorgan Annual Healthcare Conference
oday that its corporate presentation will be webcast live by JPMorgan on Wednesday, January 14, 2009 at 12:30 p.m.

EST (9:30 a.m.

PST).

David Broecker, CEO of Alkermes, will provide a strategic overview of the company and present the...

TradingMarkets:  Jan 7 2009 9:35PM
Matching: schizophrenia
Find similar documents
HTML
100%
US not ready to approve Lilly's long-acting Zyprexa
WASHINGTON, Jan 7 (Reuters) - U.S.

regulators have delayed a final decision on whether to approve Eli Lilly and Co's long-acting form of its blockbuster schizophrenia drug Zyprexa, a Food and Drug Administration spokeswoman said on...

Sharewatch:  Jan 7 2009 9:34PM
Matching: schizophrenia
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at JPMorgan Annual Healthcare Conference
Corporate Presentation to be Webcast at JPMorgan Annual care Conference - Forbes.com nology Enterprise Personal Emerging nology All Forbes nology & The World nology Wire Alkermes' Corporate Presentation to be Webcast at JPMorgan Annual...
Forbes.com:  Jan 7 2009 9:24PM
Matching: schizophrenia
Find similar documents
HTML
100%
Alkermes Corporate Presentation to be Webcast at JPMorgan Annual Healthcare Conference
Company Website: http:www.alkermes.comCAMBRIDGE, Mass.

-- (Business Wire) Alkermes, Inc.

(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by JPMorgan on Wednesday, January 14, 2009 at 12:30 p.m.

EST ...

Stockwatch:  Jan 7 2009 9:02PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episo
Arranz B et al.

- Authors findings support the view that NARP is a highly distinctive condition different from either affective psychosis or other non-affective psychosis such as schizophrenia, and highlight the need for its...

MDLinx:  Jan 7 2009 7:56AM
Matching: schizophrenia
Find similar documents
HTML
100%
Predictors of antipsychotic-induced weight gain identified
MedWire News: Antipsychotic-induced weight gain is predicted by parents' and patients' premorbid body mass index (BMI), female gender, younger age, and, partially, schizophrenia spectrum disorder diagnosis, German study findings...
MedWire News:  Jan 7 2009 12:13AM
Matching: schizophrenia
Find similar documents
HTML
100%
The metabolic syndrome and schizophrenia
Meyer JM et al.

- Because of lifestyle, disease and medication effects, schizophrenia patients have significant risk for cardiometabolic disease.

The metabolic syndrome and schizophrenia.

MDLinx:  Jan 6 2009 11:19PM
Matching: schizophrenia
Find similar documents
HTML
100%
NIDA Report Sheds Light on Comorbidity of Addiction, Other Mental Health Illnesses
Report's Release Coincides With Meeting on Comorbidities in the Military January 6, 2009 A National Institute on Drug Abuse (NIDA) research report issued today sheds light on the complex link between addiction and other mental health...
Medscape:  Jan 6 2009 10:53PM
Matching: schizophrenia
Find similar documents
HTML
100%
Critical period of illness confirmed in early schizophrenia
MedWire News: Patients with schizophrenia experience a critical period of illness 4-5 years after the onset of symptoms, during which time they deteriorate rapidly and then stabilize or improve slightly, study results show.
MedWire News:  Jan 6 2009 12:56AM
Matching: schizophrenia
Find similar documents
HTML
100%
Queen to honour Marilyn for mental health campaigning
A tireless mental health campaigner has been rewarded with an MBE.

Marilyn Lazarus, from Mill Hill, started JAMI, the Jewish Association for the Mentally Ill, more than 20 years ago after her daughter was diagnosed with schizophrenia....

The Ham and High:  Jan 6 2009 7:33PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Staffs Up
Edward Scolnick and Finny Kuruvilla have joined Clarus Ventures as a venture partner and principal, respectively.

Scolnick is the former president of Merck Research Labs, and most recently was director of the Stanley Center for Psychiatric...

Private Equity HUB:  Jan 6 2009 11:37AM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

& SOUTH SAN FRANCISCO, Calif., Jan.

5, 2009 Clarus Ventures, LLC (Clarus Ventures), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner and Finny...

Pharma Live:  Jan 5 2009 4:48PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

PR Newswire:  Jan 5 2009 4:22PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

Montana's News Station:  Jan 5 2009 3:35PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

Forbes.com:  Jan 5 2009 3:12PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

PR Newswire via Yahoo!:  Jan 5 2009 3:06PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRwire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick , M.D., as a Venture Partner and...

San Francisco Business Times:  Jan 5 2009 2:39PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

Atlanta Business Chronicle:  Jan 5 2009 2:36PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

Portland Business Journal:  Jan 5 2009 2:35PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick , M.D., as a Venture Partner and Finny Kuruvilla, M.D., Ph.

D., as a Principal in the Firm's Cambridge,...

The Business Journal Phoenix:  Jan 5 2009 2:33PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

Nashville Business Journal:  Jan 5 2009 2:33PM
Matching: schizophrenia
Find similar documents
HTML
100%
Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
CAMBRIDGE, Mass.

and SOUTH SAN FRANCISCO, Calif., Jan.

5 /PRNewswire/ -- Clarus Ventures, LLC ('Clarus Ventures'), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner...

San Antonio Business Journal:  Jan 5 2009 2:31PM
Matching: schizophrenia
Find similar documents
HTML
100%
AstraZeneca spent more than $1.3 million lobbying US government in third quarter
Article Tools Smaller| Larger Text Story Tools WASHINGTON (AP) - British drugmaker AstraZeneca PLC spent more than $1.3 million in the third quarter lobbying the U.S.

federal government, according to a recent disclosure form.

The company...

Canadian Business Magazine:  Jan 5 2009 2:27PM
Matching: schizophrenia
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.